A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs ABT 072; Ketoconazole
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 24 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2009 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 30 May 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.